Evidence map›Paper›PMID 27761146›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2016

The Multifunctional Effects of Nobiletin and Its Metabolites

Hao Huang, Linfu Li, Weimei Shi, Hai Liu, Jianqiong Yang, Xiaoliang Yuan, Longhuo Wu

Open access · hybridAbstract readReview
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
12.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Hepatoprotective effect of Nobiletin against 5-fluorouracil induce hepatotoxicity.Current research in pharmacology and drug discovery · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hao HuangCollege of Pharmacy, Gannan Medical University, Ganzhou 341000, China.ORCID 0000-0002-7788-5519
Linfu LiCollege of Pharmacy, Gannan Medical University, Ganzhou 341000, China.
Weimei ShiCollege of Pharmacy, Gannan Medical University, Ganzhou 341000, China.
Hai LiuCollege of Pharmacy, Gannan Medical University, Ganzhou 341000, China.
Jianqiong YangDepartment of Clinical Research Center, The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China.
Xiaoliang YuanDepartment of Respiratory Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China.ORCID 0000-0003-2479-0361
Longhuo WuCollege of Pharmacy, Gannan Medical University, Ganzhou 341000, China.ORCID 0000-0002-3899-9599
Gannan Medical University · CNFirst Affiliated Hospital of Gannan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nobiletin (NOB) chemically known as 5,6,7,8,3',4'-hexamethoxyflavone is a dietary polymethoxylated flavonoid found in

Identifiers

PMID27761146
PMCPMC5059563
OpenAlexW2524248777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.